Sunho Biologics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Public

  • Employees
  • 124

Employees

  • Stock Symbol
  • 02898

Stock Symbol

  • Share Price
  • $0.57
  • (As of Thursday Closing)

Sunho Biologics General Information

Description

Sunho Biologics Inc is a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of biologics for the treatment of cancers and autoimmune diseases. It has three Core Products, IAH0968, IAP0971, and IAE0972, all of which are developed in-house. IAH0968 is an antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced monoclonal antibody (mAb), and the company has initiated Phase II clinical trials for biliary tract carcinoma (BTC) and colorectal cancer (CRC). IAP0971 and IAE0972 are both immunocytokines and It has completed Phase I clinical trials for advanced solid tumors including non-small cell lung cancer (NSCLC) and CRC.

Contact Information

Website
www.sunho-bio.com
Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 5, Xingjian Road
  • Nanjing Economic and Technological Development Zone
  • Nanjing, Jiangsu
  • China
+86 025
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
HKG
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • No. 5, Xingjian Road
  • Nanjing Economic and Technological Development Zone
  • Nanjing, Jiangsu
  • China
+86 025

Sunho Biologics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sunho Biologics Stock Performance

As of 05-Dec-2024, Sunho Biologics’s stock price is $0.57. Its current market cap is $88.2M with 157M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.57 $0.56 $0.53 - $1.97 $88.2M 157M 12.6K -$0.11

Sunho Biologics Financials Summary

As of 30-Jun-2024, Sunho Biologics has a trailing 12-month revenue of $28.9K.

In Thousands,
USD 		TTM 30-Jun-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 113,083
Revenue 29 29 257 499
EBITDA (15,486) (17,928) (5,661)
Net Income (14,909) (18,757) (7,720)
Total Assets 80,815 40,974 10,271
Total Debt 4,099 1,280 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sunho Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sunho Biologics‘s full profile, request access.

Request a free trial

Sunho Biologics Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 6

    Pending

  • Expiring in next 12 mo

Sunho Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240392007-A1 Heterodimeric protein and application thereof Pending 27-Sep-2021
US-20240336682-A1 Multispecific antigen-binding protein and use thereof Pending 02-Aug-2021
US-20240327543-A1 Multispecific antigen-binding protein and use thereof Pending 02-Aug-2021
US-20240218065-A1 Multispecific antigen-binding protein and use thereof Pending 15-Jun-2021
US-20240150460-A1 Anti-nkp30 antibody and application thereof Pending 26-Feb-2021 C07K16/2803
To view Sunho Biologics’s complete patent history, request access »

Sunho Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sunho Biologics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sunho Biologics‘s full profile, request access.

Request a free trial

Sunho Biologics FAQs

  • When was Sunho Biologics founded?

    Sunho Biologics was founded in 2018.

  • Where is Sunho Biologics headquartered?

    Sunho Biologics is headquartered in Nanjing, China.

  • What is the size of Sunho Biologics?

    Sunho Biologics has 124 total employees.

  • What industry is Sunho Biologics in?

    Sunho Biologics’s primary industry is Drug Discovery.

  • Is Sunho Biologics a private or public company?

    Sunho Biologics is a Public company.

  • What is Sunho Biologics’s stock symbol?

    The ticker symbol for Sunho Biologics is 02898.

  • What is the current stock price of Sunho Biologics?

    As of 05-Dec-2024 the stock price of Sunho Biologics is $0.57.

  • What is the current market cap of Sunho Biologics?

    The current market capitalization of Sunho Biologics is $88.2M.

  • What is Sunho Biologics’s current revenue?

    The trailing twelve month revenue for Sunho Biologics is $28.9K.

  • What is Sunho Biologics’s annual earnings per share (EPS)?

    Sunho Biologics’s EPS for 12 months was -$0.11.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »